In Moscow in the framework of the criminal case concerning the former employee of the pharmaceutical company Roche, the police amazing the pharmaceutical warehouse of the company “System” and seized documents and equipment, says RBC.
A search in the case of fraud committed by an organized group or in especially large size (part 4 of article 159 of the criminal code), passed in mid-July at the following address: Leninskaya Sloboda, 32.
As previously reported, the Main investigation Department of the Moi in St. Petersburg and the Leningrad region opened two criminal cases against former employees of Roche. According to investigators, an unidentified person and former employees of the pharmaceutical company stole and resold the drug “MabThera” (rituximab MNN) totaling about 60 million virtually any.
The first case was initiated in June 2017 under part 4 of article 159 of the criminal code (fraud in especially large scale, committed by an organized group) against unidentified persons. it is believed that they illegally received from the doctors of the city clinical oncological dispensary of St. Petersburg recipes on 558 packages of rituximab 500 mg and 806 packs 100 mg and Packed them in the pharmacy number 5 network “Petersburg drugstores”. Budget, due to the theft and resale of drugs could lose up to 55 million virtually any.
At the end of January 2018, a criminal case under part 4 of article 159 of the criminal code, but in respect of the former regional Manager Roche Vladislav Alexandrov, who since 2014 the company is not working, and the inhabitant of Ekaterinburg Yevgeny Zakharov. It is assumed that crimes were committed in the period from 2013 to 2015, when the doctors of the city hospital of St. Petersburg No. 15 was discharged for Alexandrova and Zakharova 34 packing rituximab 500 mg and 31 pack of 100 mg for a total amount of 2,9 million virtually any Drugs could pass through an affiliated with the world company “NPP Rosegold”.
As stated earlier, “PV”, the head of the legal Affairs, compliance and corporate communications Roche in Russia Inna Panteleeva, the company is currently cooperating with the investigation.
“Roche is committed to high standards of compliance in terms of interaction with the medical community and other participants of the market – any interaction is strictly within the rules of the international Roche group, existing legislation and industrial codes. Collaboration with the medical community based on clear criteria and limited scope research activities”, she added.